AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11913598 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium supplementation
Number of subjects: 112
Study 10190422 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy
Number of subjects: 67
Study 10190422 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 67
Study 17974421 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐alpha(OH) vitamin D3 (0.25 mcg twice a day)
Number of subjects: 20
Study 17974421 — intervention group
Group type: COMPARATOR
Intervention: Placebo with calcium (500 mg daily)
Number of subjects: 20
Study 2167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical surgery or optimal debulking
Number of subjects: 361
Study 2167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal debulking and exploratory laparotomy
Number of subjects: 361
Study 2167280 — intervention group
Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 361
Study 2167280 — intervention group
Group type: COMPARATOR
Intervention: Optimal tumor reduction
Number of subjects: 361
Study 2167280 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal tumor reduction
Number of subjects: 361
Study 2167280 — intervention group
Group type: COMPARATOR
Intervention: Exploratory laparotomy
Number of subjects: 361
Study 2167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary tumor reduction
Number of subjects: 361
Study 2167280 — intervention group
Group type: COMPARATOR
Intervention: No secondary tumor reduction
Number of subjects: 361
Study 30883986 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (PEI video/booklet)
Number of subjects: 119
Study 30883986 — intervention group
Group type: COMPARATOR
Intervention: Control (factsheet)
Number of subjects: 119
Study 29658314 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold recruitment approach (phone calls to companies on a purchased list)
Number of subjects: 78
Study 29658314 — intervention group
Group type: EXPERIMENTAL
Intervention: Lukewarm recruitment approach (phone calls to a list of eligible companies provided by a health insurer)
Number of subjects: 78
Study 29658314 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm recruitment approach (personal referrals from local health insurers and brokers)
Number of subjects: 78
Study 29658314 — intervention group
Group type: COMPARATOR
Intervention: Cold recruitment approach
Number of subjects: 78
Study 27082747 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatments for substance use (specifics not provided)
Number of subjects: 194
Study 25087414 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous laser blood irradiation for 10 days, using a laser therapeutic device Matrix - VLOK with two radiating heads (KI-VLOK-63 and KI-VLOK-365).
Number of subjects: 132
Study 25087414 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 132
Study 22353207 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 exergames (high choice)
Number of subjects: 44
Study 22353207 — intervention group
Group type: COMPARATOR
Intervention: 3 traditional games (high choice)
Number of subjects: 44
Study 22353207 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice (1 toy vs 3 toys)
Number of subjects: 44
Study 22353207 — intervention group
Group type: COMPARATOR
Intervention: Traditional games
Number of subjects: 44
Study 22353207 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergames
Number of subjects: 44
Study 22112211 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy-led home based physical activity program
Number of subjects: 0
Study 22112211 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 17664246 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic citalopram
Number of subjects: 20
Study 17664246 — intervention group
Group type: COMPARATOR
Intervention: Celexa
Number of subjects: 20
Study 16273348 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 15
Study 16273348 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 15
Study 12022320 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention groups (3 types)
Number of subjects: 128
Study 12022320 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study 10084637 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/day risperidone
Number of subjects: 625
Study 10084637 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/day risperidone
Number of subjects: 625
Study 10084637 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/day risperidone
Number of subjects: 625
Study 10084637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 625
Study 7474246 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol (0.5%) eye drops
Number of subjects: 13
Study 7474246 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol (0.5%) eye drops with oral quinidine (50 mg)
Number of subjects: 13
Study 7474246 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 13
Study 2270452 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (i.v.)
Number of subjects: 0
Study 2270452 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (i.v.)
Number of subjects: 0
Study 2270452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6780356 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute ethanol ingestion (1.316 mol)
Number of subjects: 8
Study 31711474 — intervention group
Group type: EXPERIMENTAL
Intervention: Nickel titanium rotary instruments (NiTi‐RIs)
Number of subjects: 775
Study 28859091 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement-to-music video program (from week 2 to week 8)
Number of subjects: 228
Study 28859091 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 228
Study 28859091 — intervention group
Group type: EXPERIMENTAL
Intervention: Children at home (instead of daycare/preschool)
Number of subjects: 228
Study 28859091 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher body mass index of mothers
Number of subjects: 228
Study 25845393 — intervention group
Group type: COMPARATOR
Intervention: Standard of care arm
Number of subjects: 600
Study 25845393 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily reminders via alarm and follow-up calls from peer-educators
Number of subjects: 600
Study 25845393 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by peer-educators (in addition to second arm activities)
Number of subjects: 600
Study 23868085 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (250 mmol/day)
Number of subjects: 36
Study 23868085 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (250 mmol/day) during exercise
Number of subjects: 36
Study 21334682 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT Secur™ single incision sling
Number of subjects: 194
Study 21334682 — intervention group
Group type: COMPARATOR
Intervention: TVT™ Obturator System
Number of subjects: 194
Study 19058060 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance-strategy training program (twice-weekly for 12 weeks)
Number of subjects: 50
Study 17311976 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk containing 4 x 10(10) live cells of Lactobacillus casei strain Shirota
Number of subjects: 19
Study 15289275 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) induced by administering capsules containing an amino acid mixture without tryptophan.
Number of subjects: 27
Study 15289275 — intervention group
Group type: COMPARATOR
Intervention: Sham depletion using identical capsules containing hydrous lactose.
Number of subjects: 27
Study 11125388 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus fascia
Number of subjects: 50
Study 11125388 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 50
Study 9777688 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant therapy
Number of subjects: 0
Study 9777688 — intervention group
Group type: COMPARATOR
Intervention: Traditional ordinary least squares regression
Number of subjects: 0
Study 7849168 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior mesenteric artery reimplantation
Number of subjects: 10
Study 7849168 — intervention group
Group type: COMPARATOR
Intervention: No inferior mesenteric artery reimplantation (Control)
Number of subjects: 10
Study 7849168 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without reimplantation)
Number of subjects: 10
Study 3240762 — intervention group
Group type: EXPERIMENTAL
Intervention: furosemide-retard/triamterene
Number of subjects: 10
Study 3240762 — intervention group
Group type: COMPARATOR
Intervention: furosemide-retard
Number of subjects: 10
Study 3240762 — intervention group
Group type: EXPERIMENTAL
Intervention: furosemide
Number of subjects: 10
Study 3240762 — intervention group
Group type: EXPERIMENTAL
Intervention: OH-TA-sulphate
Number of subjects: 10
Study 29771362 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep condition
Number of subjects: 0
Study 29771362 — intervention group
Group type: COMPARATOR
Intervention: Wakefulness condition
Number of subjects: 0
Study 27816437 — intervention group
Group type: EXPERIMENTAL
Intervention: Def‐EX (exercise‐induced 25% energy depletion)
Number of subjects: 14
Study 27816437 — intervention group
Group type: EXPERIMENTAL
Intervention: Def‐EI (diet‐induced 25% energy depletion)
Number of subjects: 14
Study 24211819 — intervention group
Group type: EXPERIMENTAL
Intervention: InSight cognitive training
Number of subjects: 60
Study 24211819 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study 22784432 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized rapeseed oil (20 g/d)
Number of subjects: 59
Study 22784432 — intervention group
Group type: COMPARATOR
Intervention: Standard rapeseed oil (20 g/d)
Number of subjects: 59
Study 21358372 — intervention group
Group type: EXPERIMENTAL
Intervention: computer-based intervention
Number of subjects: 309
Study 21358372 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 309
Study 18289455 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane with remifentanil
Number of subjects: 64
Study 18289455 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane with remifentanil
Number of subjects: 64
Study 18289455 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Desflurane and Isoflurane)
Number of subjects: 64
Study 16497603 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT) using a nicotine skin patch for 2 weeks before the quit date, with doses of 0, 21, or 42 mg/24-hr after the quit date in combination with mecamylamine (10 mg/day).
Number of subjects: 0
Study 16497603 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine skin patch treatment
Number of subjects: 0
Study 16497603 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine skin patches with reduced-nicotine cigarettes
Number of subjects: 0
Study 15651509 — intervention group
Group type: EXPERIMENTAL
Intervention: BIPAP
Number of subjects: 24
Study 15651509 — intervention group
Group type: COMPARATOR
Intervention: PSV
Number of subjects: 24
Study 11704711 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment (exact dosage and duration not specified)
Number of subjects: 0
Study 11704711 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9397385 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal norethisterone acetate (NETA) 170 micrograms
Number of subjects: 774
Study 9397385 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal norethisterone acetate (NETA) 350 micrograms
Number of subjects: 774
Study 9397385 — intervention group
Group type: COMPARATOR
Intervention: Sequential oral progestogen (1 mg norethisterone or 20 mg dydrogesterone/day)
Number of subjects: 774
Study 9397385 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose transdermal progestogen
Number of subjects: 774
Study 9397385 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous progestogen (low-dose)
Number of subjects: 774
Study 9397385 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous progestogen (high-dose)
Number of subjects: 774
Study 9397385 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 774
Study 9397385 — intervention group
Group type: COMPARATOR
Intervention: Oral progestogen group
Number of subjects: 774
Study 7618387 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (40‐50 Gy)
Number of subjects: 0
Study 7618387 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 3148789 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (12 mg/kg.day)
Number of subjects: 16
Study 3148789 — intervention group
Group type: COMPARATOR
Intervention: carnitine-free TPN
Number of subjects: 16
Study 29117340 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanics
Number of subjects: 522
Study 29117340 — intervention group
Group type: COMPARATOR
Intervention: Non-Hispanic whites
Number of subjects: 522
Study 29117340 — intervention group
Group type: COMPARATOR
Intervention: Non-Hispanic blacks
Number of subjects: 522
Study 29117340 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental HRQL
Number of subjects: 522
Study 29117340 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical HRQL
Number of subjects: 522
Study 27390185 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing intensity (0-120% of watts corresponding to the ventilatory threshold)
Number of subjects: 46
Study 27390185 — intervention group
Group type: COMPARATOR
Intervention: Decreasing intensity (120-0%)
Number of subjects: 46
Study 23213051 — intervention group
Group type: EXPERIMENTAL
Intervention: Video books with motion pictures, music, and sounds
Number of subjects: 52
Study 23213051 — intervention group
Group type: EXPERIMENTAL
Intervention: Static books without music or sounds
Number of subjects: 52
Study 23213051 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stories with music or sounds
Number of subjects: 52
Study 23213051 — intervention group
Group type: EXPERIMENTAL
Intervention: Video stories without music or sounds
Number of subjects: 52
Study 23213051 — intervention group
Group type: EXPERIMENTAL
Intervention: Video books with music or sounds
Number of subjects: 52
Study 23213051 — intervention group
Group type: COMPARATOR
Intervention: Control condition (two stories with static illustrations without music or sounds)
Number of subjects: 52
Study 23114461 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii training (WII)
Number of subjects: 58
Study 23114461 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 58
Study 20606148 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine (1500 mg daily for 6 months)
Number of subjects: 250
Study 20606148 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for 6 months)
Number of subjects: 250
Study 20606148 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine
Number of subjects: 250
Study 20606148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 18680606 — intervention group
Group type: EXPERIMENTAL
Intervention: Caseload (one-to-one) midwifery care
Number of subjects: 2008
Study 18680606 — intervention group
Group type: COMPARATOR
Intervention: Standard low risk care
Number of subjects: 2008
Study 16798633 — intervention group
Group type: EXPERIMENTAL
Intervention: Learned resourcefulness training (LRT)
Number of subjects: 89
Study 16798633 — intervention group
Group type: COMPARATOR
Intervention: Focused reflection reminiscence (FRR)
Number of subjects: 89
Study 12887260 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐beta treatment
Number of subjects: 0
Study 10408819 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 120
Study 10408819 — intervention group
Group type: COMPARATOR
Intervention: Droperidol 1.25 mg
Number of subjects: 120
Study 7627484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual energy X‐ray absorptiometry (DXA) scan of the spine and hip
Number of subjects: 0
Study 7627484 — intervention group
Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation (BUA) scan of os calcis
Number of subjects: 0
Study 7627484 — intervention group
Group type: COMPARATOR
Intervention: None specified
Number of subjects: 0
Study 2484835 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprinosine
Number of subjects: 30
Study 2484835 — intervention group
Group type: COMPARATOR
Intervention: Amantadine
Number of subjects: 30
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon (color)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Live action film (color)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Pixilation film (color)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon (black and white)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Live action film (black and white)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Pixilation film (black and white)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Real human beings (as visual stimuli)
Number of subjects: 70
Study 70171 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated characters (as visual stimuli)
Number of subjects: 70
Study 31276804 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition intervention (4 months long, focused on heart-transplant knowledge, self-care, self-advocacy, and social support)
Number of subjects: 0
Study 31276804 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 28273737 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated bioactive stents (BAS)
Number of subjects: 827
Study 28273737 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827
Study 25945760 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with fixed appliances
Number of subjects: 20
Study 25945760 — intervention group
Group type: COMPARATOR
Intervention: Control group (without orthodontic treatment)
Number of subjects: 20
Study 24345758 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 49
Study 24345758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 22490861 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFU combined with gemcitabine
Number of subjects: 48
Study 22490861 — intervention group
Group type: COMPARATOR
Intervention: HIFU alone
Number of subjects: 48
Study 19413646 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-RW (web-based self-help intervention)
Number of subjects: 378
Study 17322143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 24
Study 17322143 — intervention group
Group type: COMPARATOR
Intervention: Ethanol 0.5 g/kg
Number of subjects: 24
Study 15356550 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dosimeter method (5 breath to total lung capacity)
Number of subjects: 16
Study 15356550 — intervention group
Group type: COMPARATOR
Intervention: Modified dosimeter challenge (submaximal inhalations to approximately 50% to 60% below TLC)
Number of subjects: 16
Study 11590628 — intervention group
Group type: EXPERIMENTAL
Intervention: Rank-based methods for analysis of outcomes with rescue medication
Number of subjects: 0
Study 11590628 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel regression model relating outcome to allocated treatment and rescue status
Number of subjects: 0
Study 9850355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual X-ray absorptiometry (DXA)
Number of subjects: 165
Study 9850355 — intervention group
Group type: COMPARATOR
Intervention: Peripheral quantitative computed tomography (pQCT)
Number of subjects: 165
Study 8022438 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E2 (20 mg intravaginally every 3 hours)
Number of subjects: 55
Study 8022438 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms intravaginally every 12 hours)
Number of subjects: 55
Study 3692908 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet (20% energy from fat)
Number of subjects: 31
Study 3692908 — intervention group
Group type: COMPARATOR
Intervention: High fat diet (40% energy from fat)
Number of subjects: 31
Study 29186982 — intervention group
Group type: EXPERIMENTAL
Intervention: Making Your Wishes Known (MYWK): Comprehensive ACP decision aid including education and values clarification.
Number of subjects: 285
Study 29186982 — intervention group
Group type: COMPARATOR
Intervention: Basic ACP: state‐approved online advance directive plus brochure.
Number of subjects: 285
Study 29186982 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP done together with family members.
Number of subjects: 285
Study 29186982 — intervention group
Group type: COMPARATOR
Intervention: ACP done by patients alone.
Number of subjects: 285
Study 29186982 — intervention group
Group type: EXPERIMENTAL
Intervention: Making Your Wishes Known (MYWK) vs Basic ACP
Number of subjects: 285
Study 27424046 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract extraction with contact lens correction
Number of subjects: 114
Study 27424046 — intervention group
Group type: COMPARATOR
Intervention: Implantation of an intraocular lens
Number of subjects: 114
Study 24395021 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine (2 or 3 mg)
Number of subjects: 40
Study 24395021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 22383605 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional video CD (VCD) and study guide
Number of subjects: 2
Study 22383605 — intervention group
Group type: COMPARATOR
Intervention: Live patient training (Control Group A)
Number of subjects: 2
Study 20694776 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese drugs administered by both oral intake and retention enema (Group A)
Number of subjects: 78
Study 20694776 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese drugs given by retention enema only (Group B)
Number of subjects: 78
Study 20694776 — intervention group
Group type: COMPARATOR
Intervention: Western medicine (Group C)
Number of subjects: 78